Sold as Alcohol 5% And Dextrose 5%. Every FDA application for this active ingredient.
As of Nov 14, 2026, FDA lists 1 application for Alcohol; Dextrose (sold as Alcohol 5% And Dextrose 5%), first approved Jan 17, 1946, with 0 new uses approved and 0 published complete response letters.
| Imaging Mitochondrial Complex-I in Alcohol Use DisorderAlcohol Use Disorder (AUD), Healthy Controls Group - Age and Sex-matched · Rajesh Narendran | Early phase 1 | Recruiting | Sep 17, 2026 |
| Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in ChildrenFungal Infection by Site, Tinea Capitis · Sohag University | — | Not yet recruiting | Sep 3, 2026 |
| Prenatal Exercise and Glucose RegulationGestational Diabetes Mellitus, Gestational Diabetes Mellitus in Pregnancy · University of Central Arkansas | Not applicable | Recruiting | Sep 3, 2026 |
| Clinical, Dermoscopic, and Mycological Evaluations of Resistant DermatophytosisFungal Skin Infection, Tinea Corporis · Sohag University | — | Not yet recruiting | Sep 1, 2026 |
| A Cohort Study on the Integrated Management of Chronic Kidney DiseaseChronic Kidney Disease, Stage 5, Chronic Kidney Disease, Stage 4 · Huashan Hospital | — | Not yet recruiting | Jul 17, 2026 |
| The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes MellitusGestational Diabetes Mellitus (GDM) · Medical University of Vienna | Not applicable | Recruiting | Jul 6, 2026 |
| Family FINGER: Lifestyle Intervention Among Older CaregiversPositive Mental Health · Tarja Välimäki | Not applicable | Recruiting | Jun 4, 2026 |
| Immun4Cure Cohort of Autoimmune DiseasesRheumatoid Arthritis, Systemic Lupus Erythematosus · University Hospital, Montpellier | — | Recruiting | Apr 7, 2026 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Jan 17, 1946 | Alcohol 5% And Dextrose 5%NDA 4589 | B Braun | 9 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
